© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Roxithromycin owes its origins to a growing need for improved macrolide antibiotics during the late twentieth century. In the decades leading up to its introduction, researchers sought to fix problems seen with earlier drugs like erythromycin—such as bitter taste, stomach upset, and quick breakdown in the body. French pharmaceutical scientists developed roxithromycin by adding a nitrogen-containing ring to the erythromycin molecule. The change wasn’t just cosmetic. It allowed the new drug to fight a broader range of bacteria and hang around longer in the blood, giving doctors another weapon in the fight against respiratory and soft tissue infections. The 1987 approval in Europe opened the door to worldwide use, and roxithromycin quickly found its way onto pharmacy shelves from Asia to Australia. Since then, its presence became common in general practice.
Roxithromycin earned a reputation as a go-to treatment for infections affecting the respiratory tract, skin, and soft tissue. The product usually appears as film-coated tablets or powder for oral suspension. Doses range from 150 mg to 300 mg, taken once or twice a day. A lot of doctors—myself included—turned to roxithromycin for patients allergic to penicillin or those who couldn't handle other antibiotics. By the turn of the millennium, one could find prescription guidelines for adults and children across hospital formularies. Its higher acid stability, compared to older macrolides, meant patients could eat meals without losing effectiveness.
Roxithromycin, a white to yellowish crystalline solid, does not dissolve well in water, but it blends easily with alcohol and some organic solvents. Its chemical formula is C41H76N2O15, with a molecular weight of about 837.1 g/mol. Unlike many other antibiotics, roxithromycin resists stomach acid, which means it gets absorbed well from the gut. That resistance shows up in its structural features: the addition of a morpholine ring and a few tweaks to its sugar side-chains gave this compound a real boost. The melting point stands at about 112–114°C. The smell is barely noticeable, which lines up with most macrolide antibiotics.
Pharmaceutical companies must stick to rigorous standards for roxithromycin, down to the last microgram. Purity should hit at least 98%, with strict limits on related substances and impurities spelled out by United States Pharmacopeia (USP) and European Pharmacopoeia (EP) guidelines. Tablets require accurate labeling—each must clearly state the dose, batch number, and expiry date. The humidity and temperature of storage rooms matter since roxithromycin breaks down if it sits too long in moist air. Suspensions for kids get measured for content uniformity and safety checks before leaving the factory floor. Pharmacists and hospitals keep logs to trace each shipment. This approach doesn’t just meet regulations; it builds public trust.
Early steps in roxithromycin’s preparation involve chemical modifications of erythromycin A. Chemists react erythromycin with specific agents to open its lactone ring, attach a morpholine group, and reseal the molecule. The process has several filtration and purification steps where solvents are recycled and dried for reuse—a sign of growing environmental awareness in the industry. Factories use enclosed reactors with computer control to dodge contamination. Each crystallization batch gets tested for impurities with high-performance liquid chromatography (HPLC). The method is efficient and repeatable—important for keeping prices fair and products safe.
The backbone of roxithromycin comes from older macrolide scaffolds. The big leap forward happened with the addition of a morpholine ring, which increases stability in acidic environments and blocks certain bacterial enzymes that break down drugs. The chemical process relies on careful pH adjustments. Oxidizing agents and protecting groups shape the molecule and prevent unwanted side reactions. Final hydrogenation steps ensure few byproducts make it past quality checks. Researchers tinkered with further modifications—like adding fluorine atoms and tinkering with sugars—to create next-generation antibiotics, but the core morpholine modification remains crucial for roxithromycin’s standout properties.
Roxithromycin pops up under a variety of names in doctor’s offices and pharmacy windows: Rulid, Surlid, Roxar, and Roximycin are just a few of the brand names seen from Europe to Australia. In academic papers, chemical synonyms include (E)-9-[(2-methoxyethoxy)methyl]erythromycin O-oxime, and simply ‘ROX’ in shorthand. These aliases occasionally cause confusion for patients picking up refills abroad. Licensed producers maintain distinctive branding to stand out—but the active ingredient remains the same.
Patient safety drives every aspect of roxithromycin handling, starting with packaging that protects the drug from light and air. Medical staff receive training on recognizing drug interactions, as roxithromycin can increase blood levels of other medicines like warfarin and theophylline. Factories test batches for heavy metals, microbial contamination, and particle size. Storage rooms run at 20–25°C, away from moisture. Pharmacists warn about potential side effects—including nausea, headaches, or rare allergic reactions—and advise patients not to share antibiotics. Hospitals in many countries list roxithromycin in their official formularies, a sign of its clinical reliability and manageable risk profile. Ongoing pharmacovigilance programs collect data from doctors and patients to catch any unexpected safety signals over time.
Roxithromycin’s reach covers bacterial infections of the throat, sinuses, chest, ears, skin, and soft tissue. Doctors favor it for patients allergic to beta-lactam antibiotics or facing drug-resistant bugs. The long half-life means two-a-day dosing, making treatment easier for older adults or those juggling multiple medications. Pediatricians prescribe liquid formulas for children with whooping cough or tonsillitis. Dentists use roxithromycin before oral surgery for at-risk patients. In some cases, the drug steps in for travelers headed to regions with high rates of resistant strep and staph bacteria. Veterinary medicine also draws from the human playbook: roxithromycin finds use in treating infections in livestock and pets, although these uses are tightly controlled in many countries to slow resistance buildup.
Interest in macrolides hasn’t faded, and scientists continue to study how roxithromycin interacts with both human and bacterial cells. Projects track the drug’s ability to reduce inflammation in chronic lung diseases like COPD and bronchiectasis. Clinical trials explore new combinations—pairing roxithromycin with other antibiotics or adding it to support treatment for chronic sinusitis. Meanwhile, epidemiologists watch bacterial resistance rates, which can shift fast with widespread antibiotic use. Drug designers hope to craft new generations that overcome resistance without wrecking the gut microbiome. Collaborative networks between universities, hospitals, and industry share results so each new breakthrough builds on the past.
Toxicologists have studied roxithromycin’s safety since its earliest clinical trials. Most side effects are mild, with nausea and digestive upset leading the list, but rare cases include liver inflammation and allergic skin rashes. Animal studies set early dose limits, while volunteer studies fine-tuned human recommendations. As part of my practice, I’ve watched patients for irregular heart rhythms, especially those taking other medicines that affect the heart’s electrical signal. Toxicity research led regulators to add warning labels about possible interactions and signs of severe liver injury. Authorities continue to collect real-world safety reports through national monitoring programs. Modern post-marketing surveillance means changes reach prescribing guidelines faster when problems appear.
Roxithromycin’s future is tied to both its clinical role and the global battle against antibiotic resistance. Evidence keeps stacking up for its benefits in patients with specific needs—especially those who can’t use penicillins. At the same time, public health experts call for careful antibiotic stewardship. New research looks into using roxithromycin for inflammatory diseases beyond infection, such as cystic fibrosis. Advances in drug delivery—like slow-release tablets—could improve patient comfort and cut missed doses. Universities and industry labs dig into modifications that might turn roxithromycin into a springboard for building smart macrolide hybrids. Cost pressures may shift production toward generic markets, especially in countries with growing antibiotic demand. Success in meeting these challenges will depend on open collaboration between researchers, clear public information, and government support for both safety and drug access. Roxithromycin may be a product of the past century, but its evolution reflects the ongoing story of science, industry, and care for people.
Doctors in many countries reach for roxithromycin when faced with stubborn bacterial infections. This antibiotic, part of the macrolide family, gets prescribed to folks dealing with infections like bronchitis, tonsillitis, or sinus infections. I’ve seen folks around me knock down a persistent cough or sore throat after a few days on a regimen their doctor set. This medicine clears up issues that often don't respond well to over-the-counter treatments.
Many people ask why a doctor might pick roxithromycin instead of some older antibiotics like penicillin. Plenty of people have allergies to penicillin, and roxithromycin offers an alternative. Some bacteria are starting to laugh off traditional antibiotics, so doctors need new ways to tackle them. Roxithromycin helps slow or stop the spread of these stronger bacteria. Research published in the International Journal of Antimicrobial Agents shows that drugs like roxithromycin keep performing well against respiratory tract bugs resistant to older choices.
Anyone who’s dealt with recurring sinus infections or skin inflammations knows the frustration that comes from another round of failed treatments. My own neighbor, a busy teacher, once saw her daily routine come to a grinding halt because of a deep chest infection. Her doctor recommended roxithromycin, and after a few days, she got back on her feet. It’s not a miracle pill, but for many, it’s the turning point in their recovery.
The real trouble comes when people self-medicate or pressure their doctor for antibiotics when they’re not needed. Antimicrobial resistance isn’t just a scary headline — it shows up in clinics where treatments don’t work as well anymore. According to the World Health Organization, more than 2.8 million people get an antibiotic-resistant infection every year, just in the U.S. That’s a heavy price for taking antibiotics for the wrong reasons.
Better education plays a big part. Doctors, pharmacists, and nurses need to talk with patients about the real reasons for taking antibiotics and why it’s a bad idea to save pills for later or share them with a neighbor. Tracking how often drugs like roxithromycin actually help, and sharing those results, add up to bigger changes in prescribing habits. Hospitals and clinics digging into their own local data on resistance help doctors make smarter choices every day.
No one wants to lose the tools doctors rely on, especially with common infections still sending folks to the hospital. Roxithromycin remains a good choice for people in need, but seeing it as a trusted tool — not a cure-all — helps future generations stay protected. Informed choices and honest conversations between patients and their healthcare team go a long way in keeping antibiotics like roxithromycin working for everyone.
Every medicine you take brings the hope of getting better, but some pills give a little payback in the process. Roxithromycin, often prescribed for chest, throat, ear, and skin infections, does the heavy lifting against bacteria. Yet it can put up a list of side effects that catch a lot of folks off guard. Upset stomach comes in early for many. Stomach pain, nausea, and sometimes a few runs to the bathroom are not rare mentions. I remember a neighbor once saying she felt queasy after just two doses, her appetite shutting down almost instantly. That’s hardly unique. Taking Roxithromycin on an empty stomach can make this worse.
Doctors often hear the usual suspects: loose stools, cramps, and a strange metallic taste. In medical studies, almost one in ten patients talks about some form of stomach problem while on this drug. Those issues become a real nuisance, especially for older adults or anyone prone to dehydration. Doctors recommend drinking plenty of fluids. For folks who can’t shake the runs, sometimes switching to a different antibiotic becomes the only option.
Skin rashes also come up from time to time. Most rashes fade when the drug moves out of your system. But every so often, someone gets a big red skin rash, swelling, or finds themselves itchy from head to toe. Rarely, someone might run into serious allergic reactions. Difficulty breathing or swelling in the mouth or face needs quick, professional help. Allergic responses to antibiotics show how unpredictable our immune systems can be. According to the Mayo Clinic, around 7% of people using macrolide antibiotics like Roxithromycin report some skin or allergy issue.
Headaches get mentioned often, and some users talk about dizziness or feeling weirdly tired. Some children start to feel restless or irritable. Changes in hearing crop up in reports, though less often. Antibiotics change the gut balance, so yeast infections can sneak in—mouth or vaginal thrush shows up in a small but real chunk of people, especially after longer courses.
Side effects shift people’s willingness to stick with a medication. The World Health Organization reports that more than half the people who get prescribed a new antibiotic don’t finish the course. For Roxithromycin, the biggest risk with stopping early involves bacteria outsmarting future treatments. Drug resistance keeps growing because people skip doses or drop out early due to unpleasant side effects.
Doctors lean on a few simple steps. They tell people to take the pill with food if the stomach protests. Extra water helps flush things out. If a rash or major stomach pain appears, a quick call to the clinic brings answers and, if needed, a different prescription. Keeping in touch with your pharmacist guides people in sorting out minor from big issues. Reporting side effects also helps regulators and companies track patterns, keeping future patients safer.
Personal experience shapes how people view medications. If you run into bothersome effects, sharing your story with your care team matters. Honest feedback helps them adjust care and warn others about what to expect. Medicines work best when safety and comfort both stay in focus. Learning about common side effects lets people make informed choices, reduces surprises, and encourages conversation between patients and health professionals.
Roxithromycin, like many antibiotics, helps fight off bacterial infections. Health care providers often suggest it for breathing problems, skin infections, or even sore throats when bacteria play the main role. It’s related to erythromycin, but people sometimes find it easier on the stomach.
Doctors mean it when they say swallow every dose as instructed. Skipping pills gives bacteria a chance to regroup, making things harder for you down the line. From my own experience, leaving antibiotics unfinished led to a drawn-out illness and an upset stomach that stuck around longer than I wanted. Taking these pills with a full glass of water makes things easier—less irritation, less aftertaste.
Some ask about food. Roxithromycin can usually be taken with or without a meal. Eating at the same time as your medicine sometimes reduces nausea or cramps. Often, the biggest challenge is remembering. I set alarms on my phone, or I put my pills next to the coffee maker each morning.
People may start to feel better in a couple of days and stop early. That mistake circles back. Bacteria that survive may become tougher to treat. Researchers from the CDC say incomplete courses of antibiotics help fuel drug-resistant strains that trouble many hospitals. We all carry some responsibility here. Taking every pill, even past the point when you feel normal, cuts down on the risk of relapsing or spreading tougher bugs to someone else.
No one likes unwanted effects, but stomach pain or nausea sometimes turn up. Most people get by if they hydrate well and avoid spicy foods for a bit. Sometimes rashes, yellowing eyes, or trouble breathing turn up—time to call your doctor right away. Rare, but worth watching out for.
Roxithromycin competes with other drugs in your body. That means some regular prescriptions like blood thinners or heart medicines could react badly. I learned to always bring a full prescription list to my check-ups, and it paid off when my doctor swapped out a medicine that would have clashed with an antibiotic.
Store your tablets in a dry, cool place—bathroom cabinets can sometimes get too humid and mess with the pills. Reaching out for a pharmacist’s advice doesn’t mean you’re bothering anyone—they love clear questions and help avoid common missteps.
No single medicine stands alone. Drinking enough water, resting, and getting good nutrition all make a difference in fighting off infections. Antibiotics help the body, but they work much better when you see the bigger picture.
Standing at the pharmacy counter, clutching a new prescription, a question pops up immediately for many women: Is this safe while I’m pregnant or breastfeeding? Roxithromycin, a macrolide antibiotic used to tackle bacterial infections, lands right in the middle of this real-world debate. It doesn’t have the household name value of penicillin or amoxicillin, but its use crops up plenty, especially when other antibiotics won’t do the trick.
Doctors prescribe antibiotics in pregnancy and during breastfeeding only after weighing benefits against risks. The body’s immune system gets busy protecting two lives instead of one. Sometimes simple infections turn risky, growing into threats for mom and baby. Roxithromycin, compared to others in its family, sits on a thinner ice for safety checks. Decades of use and clinical studies do more for drugs like erythromycin and azithromycin, but roxithromycin often flies under the radar.
Most available research on roxithromycin and pregnancy draws from animal studies, which do not line up perfectly with what happens in people. Researchers found that high doses did not cause birth defects in rats or rabbits. But, no one can promise the same results outside the lab. The big challenge? There’s a lack of human data. The Australian Therapeutic Goods Administration places roxithromycin in category B1—few pregnant women actually used it in studies, and the studies that did exist didn’t show proven problems.
In the real world of clinics and hospitals, doctors often avoid roxithromycin during pregnancy when safer, well-known alternatives exist. The reason is simple: More is known about other antibiotics. Pharmacists, doctors, and midwives have seen and tracked their use for years, with enormous amounts of data giving confidence about outcomes in babies.
With breastfeeding, the picture gets cloudier. Roxithromycin passes into breast milk in small amounts. The main risk is diarrhea or changes in a baby’s delicate gut flora, and while most babies handle this well, nobody wants to gamble with a newborn’s health. If an infection absolutely demands roxithromycin, doctors sometimes continue it with close baby monitoring. Most would swap to a drug with clearer breastfeeding safety records if possible.
No one wants to take unnecessary medicine while pregnant or trying to keep a baby healthy through breastfeeding. Sometimes, though, the mother’s health needs urgent attention—and infections won’t wait for long research projects to wrap up. Choosing an antibiotic becomes a balancing act: how risky is the infection, how effective is the medicine, and what do years of real-life experience say?
Women can play a part in safe decisions. Always tell providers about pregnancy or plans to breastfeed. Ask questions. Dive into every prescription—what problem is the antibiotic tackling, and could something safer work? Look for official sources. Pharmacies, reputable websites, and obstetric specialists give grounded, fact-based advice and warn against half-baked tips found in open internet forums.
The real challenge isn’t catching every single study about roxithromycin. It’s about open conversations, informed choices, and doctors sharing the most up-to-date facts. Sometimes, uncertainty makes these choices even harder, but honest dialogue and a healthy dose of caution protects both mother and child when options run slim.
Roxithromycin comes from the macrolide family, treating all sorts of bacterial infections. It's often used for throat, chest, or skin infections. By stopping bacteria from multiplying, the drug helps clear up illness fast. I've watched folks feel confident about its track record, but some might not realize that like with any medication, what you eat or the other pills you take can throw a curveball into your treatment.
Macrolide antibiotics can bring surprises when matched with other medicines. Roxithromycin doesn't get along with some common drugs. For example, taking it with the immune-suppressant cyclosporine can cause cyclosporine levels in the blood to climb, taxing the kidneys. The heart drug digoxin can also see its effects heightened, pushing someone toward toxicity if no one checks blood levels. Warfarin, a blood thinner, doesn't like sharing the stage with roxithromycin either. Together, the risk of bleeding rises, which doctors handle by checking blood tests and sometimes tweaking the dose.
It surprised me the first time a friend, who always keeps up with routine checkups, landed in the emergency room after eating grapefruit and starting a new antibiotic. Roxithromycin and grapefruit both run into the same liver enzymes. This fruit can slow down how fast roxithromycin breaks down, raising blood levels of the drug. The problem gets worse if a person is already on several medications that also count on those enzymes.
Many prescription drugs don’t care what’s on your dinner plate. Roxithromycin stands out because fatty foods might slow down how fast it works, though they do not ruin its effect altogether. The bigger worry comes from things like grapefruit or even large amounts of cranberry. These foods have a knack for affecting how drugs process through the liver. They can build up antibiotics like roxithromycin to higher levels than the body expects. This can make side effects more likely, including tummy troubles or in rare cases changes in heart rhythm.
Supplements and herbal teas show up everywhere, promising natural support. Most people have taken St. John’s wort or similar products at some point. This herb, for instance, can change how the liver handles medicine, lowering roxithromycin’s level in the blood so that it works less well. These interactions don't warn you with pain or a rash, so they're easily missed.
Calcium and magnesium supplements can catch people off guard. They might block the body from taking in a full dose if swallowed too close to the antibiotic—especially with other macrolides, though roxithromycin manages better than most in this department.
Staying safe starts with a simple but powerful step: sharing a full list of everything you’re taking—pills, foods, supplements, even sleepytime teas—with your healthcare provider. Pharmacists double-check these things before filling a script, but they need the right info. Reading drug info sheets and asking questions turns anyone into their own best advocate. The field of drug interactions grows all the time, so what I learned a decade ago sometimes shifts with fresh research or patient stories. Staying updated remains one of the best protections.
The bottom line: Nothing beats open conversation with your doctor and pharmacist before starting, stopping, or combining anything new with roxithromycin. It’s worth every minute spent double-checking, so the only surprise you get is a fast, smooth recovery.
| Names | |
| Preferred IUPAC name | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-6-[[2-(methoxyamino)acetyl]oxy]oxacyclotetradecane-2,10-dione |
| Other names |
Rulid Surlid Roxar Roximycin |
| Pronunciation | /ˌrɒk.sɪˈθrɒm.ɪ.sɪn/ |
| Identifiers | |
| CAS Number | 80214-83-1 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Roxithromycin**: ``` CC1OC2(C(OC1C(C)OC3(C(C(N(C2=O)C)C(=O)OC(C(C3C)O)C)C)O)C)C(=O)OCCN ``` |
| Beilstein Reference | 134496 |
| ChEBI | CHEBI:10111 |
| ChEMBL | CHEMBL1762 |
| ChemSpider | 21173782 |
| DrugBank | DB00820 |
| ECHA InfoCard | 100.086.722 |
| EC Number | 64211-45-6 |
| Gmelin Reference | 576600 |
| KEGG | D04321 |
| MeSH | D017937 |
| PubChem CID | 53839 |
| RTECS number | QS9450000 |
| UNII | FXH3T0608Z |
| UN number | UN3249 |
| CompTox Dashboard (EPA) | DTXSID5012386 |
| Properties | |
| Chemical formula | C41H76N2O15 |
| Molar mass | 837.046 g/mol |
| Appearance | white or almost white, crystalline powder |
| Odor | Odorless |
| Density | 0.94 g/cm³ |
| Solubility in water | Practically insoluble in water |
| log P | 1.63 |
| Acidity (pKa) | 7.75 |
| Basicity (pKb) | 8.50 |
| Refractive index (nD) | 1.52 |
| Dipole moment | 4.99 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 347.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -13900 kJ/mol |
| Pharmacology | |
| ATC code | J01FA06 |
| Hazards | |
| Main hazards | May cause allergic reactions, gastrointestinal disturbances, liver dysfunction, and potential QT interval prolongation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | Rx Only, Oral Use, Keep Out of Reach of Children, Do Not Use if Pregnant, Consult Physician, Store Below 25°C, Protect from Light |
| Signal word | No signal word |
| Hazard statements | Hazard statements: Not classified as hazardous according to GHS. |
| Precautionary statements | Keep out of reach of children. Use only as directed by your physician. Do not use if you are allergic to macrolide antibiotics. Store below 25°C, protect from light and moisture. Do not use after the expiry date. |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | > 195.5 °C |
| Autoignition temperature | > 350°C |
| Lethal dose or concentration | LD50 (oral, mouse): >2000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Roxithromycin: "3,500 mg/kg (oral, mouse) |
| NIOSH | Not listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 300 mg daily |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Erythromycin Azithromycin Clarithromycin Dirithromycin Oleandomycin |
